Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01152606
Other study ID # BO20652
Secondary ID
Status Completed
Phase N/A
First received June 28, 2010
Last updated January 23, 2018
Start date August 30, 2007
Est. completion date May 31, 2016

Study information

Verified date January 2018
Source Hoffmann-La Roche
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a single cohort observational safety study. All patients will be treated and monitored according to the local clinical practice. No additional procedures/patient visits in comparison with the usual clinical practice are planned for the study. Data will be collected from centre's medical records for up to 5 years or death.


Recruitment information / eligibility

Status Completed
Enrollment 3942
Est. completion date May 31, 2016
Est. primary completion date May 31, 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- All patients who are considered candidates to receive Herceptin for this indication

Exclusion Criteria:

- Patients for whom Herceptin is contraindicated

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
trastuzumab [Herceptin]
There is no planned investigational product or a treatment regimen prescribed by this protocol. Decision about a treatment regimen will be made according to the local practice and in the best interest of individual patients.

Locations

Country Name City State
Austria Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie Graz
Austria LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie Graz
Austria Lhk Klagenfurt; Abt. Für Gynäkologie Klagenfurt
Austria LKH Hochsteiermark; Abt. für Innere Medizin Leoben
Austria Ordensklinikum Linz Barmherzige Schwestern; Abt. fur Innere Medizin 1 Linz
Austria Lhk Feldkirch; Interne Medizin Abt. Rankweil
Austria Lkh Salzburg - Univ. Klinikum Salzburg; Iii. Medizinische Abt. Salzburg
Austria A. Ö. Krankenhaus Der Barmherzigen Brüder; Abt. Für Chirurgie St Veit An Der Glan
Austria A.Ö. Lhk; Ii. Medizinische Abt. Mit Schwerpunkt Gaströnter. & Onkologie Steyr
Austria Lhk Vöcklabruck; Ii. Interne Abt. Vöcklabruck
Austria Klinikum Kreuzschwestern Wels; Iv. Interne Abt. Wels
Austria Krankenanstalt Rudolfstiftung; I. Med. Abt. Wien
Austria Medizinische Universität Wien; Univ.Klinik für Frauenheilkunde - Klinik für Gynäkologie Wien
Austria Medizinische Universität Wien; Univ.Klinik für Innere Medizin I Wien
Austria Wilhelminenspital; I. Medizinische Abt. Wien
Belgium ZNA Middelheim Antwerpen
Belgium CH EpiCURA Site Louis Caty Baudour
Belgium AZ KLINA Brasschaat
Belgium AZ Sint Jan Brugge
Belgium Cliniques Universitaires St-Luc Bruxelles
Belgium HIS (Etterbeek Ixelles) Bruxelles
Belgium Hospital Erasme; Neurologie Bruxelles
Belgium UZ Antwerpen Edegem
Belgium AZ Groeninge (Kennedylaan) Kortrijk
Belgium CHU Sart-Tilman Liège
Belgium Clinique Ste-Elisabeth Namur
Belgium Clinique St Pierre asbl Ottignies
Belgium AZ Delta (Campus Wilgenstraat) Roeselare
Belgium AZ Nikolaas (Sint Niklaas) Sint Niklaas
Belgium AZ Turnhout Sint Elisabeth Turnhout
Belgium Sint Augustinus Wilrijk Wilrijk
Germany Studienzentrum Aschaffenburg Aschaffenburg
Germany Internist; Praxis Für Haemotologie & Onkologie Bad Soden
Germany Brustzentrum Bassum Bassum
Germany DRK Kliniken Berlin Köpenick, Frauenklinik Berlin
Germany Onkologische Schwerpunktpraxis Kurfürstendamm Berlin
Germany Praxis Dr Geuther Berlin
Germany Praxis Dr. Schoenegg Berlin
Germany Onkologische Schwerpunktpraxis Bielefeld; Haemotologie & Internistische onkologie Bielefeld
Germany Medizinisches Versorgungszentrum Bonn Bonn
Germany Universitätsklinikum Bonn; Zentrum für Geburtshilfe und Frauenheilkunde Bonn
Germany Med. Versorgungszentrum Filiale Donauwörth Onkologisches Zentrum Donauwörth
Germany Onkologisches Zentrum; Oncology Donauwörth
Germany St. Johannes Hospital Dortmund
Germany BAG Freiberg-Richter, Jacobasch, Illmer, Wolf Dresden
Germany Praxis im Elbcenter 1 in Dresden-Pieschen; Dr. med. Thomas Goehler & Dipl.-Med. Steffen Doerfel Dresden
Germany Universitätsklinikum "Carl Gustav Carus"; Frauenheilkunde und Geburtshilfe Dresden
Germany Universitätsklinikum Düsseldorf; Frauenklinik Düsseldorf
Germany Kreisklinik Ebersberg; Abteilung für Gynäkologie & Geburtshilfe Ebersberg
Germany Universitätsklinikum Erlangen; Frauenklinik Erlangen
Germany St Antonius Hospital; Frauenklinik Eschweiler
Germany Uniklinik Essen; Gynäkologie Essen
Germany Hämatologisch-Onkologische Gemeinschaftspraxis am Bethanien-Krankenhaus Frankfurt am Main
Germany Praxis für Interdisziplinäre Onkologie und Hämatologie GbR Freiburg
Germany Klinikum Fulda gAG; Frauenklinik Fulda
Germany Klinikum St. Georg GmbH; Franziskus-Hospital Harderberg; Klinik für Gynaekologie und Geburtshilfe Georgsmarienhütte
Germany Wilhelm-Anton-Hospital Klinik f.Hämatologie und internistische Onkologie Goch
Germany Martin-Luther-Universität Halle-Wittenberg Halle
Germany Dres. Sigrun Müller-Hagen Mathias Bertram und Ulrich Stein Hamburg
Germany Iorc-Innovation Onkologie& Research& Consulting Gmbh; Praxis Lerchenfeld Hamburg Hamburg
Germany Kooperatives Mammazentrum Hamburg Krankenhaus Jerusalem Hamburg
Germany Praxis Harburger Ring Hamburg
Germany Universitätsklinikum Hamburg-Eppendorf; Frauenklinik Hamburg
Germany SANA Klinikum Hameln-Pyrmont; Frauenklinik / Brustzentrum Hameln
Germany Diakovere Henriettenstift, Frauenklinik Hannover
Germany Medizinische Hochschule Zentrum Frauenheilkunde Abt.Gynäkologische Onkologie Hannover
Germany Stiftung Kathol. Krankenhaus Marienhospital Herne Klinik Mitte Frauenklinik Herne
Germany Universitaetsklinikum des Saarlandes; Klinik f. Frauenheilkunden und Geburtshilfe Homburg/Saar
Germany Universitätsklinikum Jena; Klinik und Poliklinik für Frauenheilkunde und Fortpflanzungsmedizin Jena
Germany Westpfalz-Klinikum GmbH; Klinik für Frauenheilkunde und Geburtshilfe Kaiserslautern
Germany Gemeinschaftspraxis Dr. Siehl & Dr. Soeling Kassel
Germany Systemedic Frauenarzte Pruener Gang Kiel
Germany Gemeinschaftspraxis Für Haematologie/Onkologie Köln
Germany Uniklinik Köln; Klinik Für Frauenheilkunde Köln
Germany Asklepios Klinik; Abt. Gynäkologie Langen
Germany Klinik Lippe Lemgo; Medizinische Klinik II/Haematoonkologie Lemgo
Germany Universitätsklinikum Schleswig-Holstein / Campus Lübeck; Klinik für Frauenheilkunde und Geburtshilfe Lübeck
Germany Onkologische Gemeinschaftspraxis Magdeburg
Germany Universitätsmedizin Mainz; Klinik u. Poliklinik f. Geburtshilfe u. Frauenheilkunde Mainz
Germany Universitätsklinikum Marburg; Gynäkologie Marburg
Germany Ev. Krankenhaus Mülheim
Germany Gemeinschaftspraxis für Hämatologie und Onkologie Münster
Germany Praxis Für Haematologie & Onkologie Dr. B. Otremba Oldenburg
Germany Praxis Frau Dr. Schwarz Oranienburg
Germany Klinikum Passau; 2. Medizinische Klinik; Onkologie und Hämatologie Passau
Germany Krankenhaus Rheinfelden; Frauenklinik Rheinfelden
Germany Agaplesion Diakonieklinikum Rotenburg Rotenburg-wuemme
Germany Caritas Klinik St. Theresia -Frauenklinik Brustzentrum Saarbruecken
Germany Klinik Saarbrücken Ggmbh; Brustzentrum Saarbruecken
Germany Praxis Dr. Wagner Saarbruecken
Germany DRK Krankenhaus Saarlouis; Kooperatives Brustzentrum Saarlouis
Germany Marienkrankenhaus Abt. Gynäkologie und Geburtshilfe Saint Wendel
Germany MVZ für Hämatologie, Onkologie, Strahlentherapie und Palliativmedizin -; Klinik Dr. Hancken Stade
Germany Johanniter-Krankenhaus Stendal
Germany Klinik Der Hansestadt Stralsund Gmbh; Frauenklinik Stralsund
Germany Klinikum Traunstein Traunstein
Germany Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie Trier
Germany Katharinen-Hospital gGmbH Unna
Germany Kliniken Nordoberpfalz; Klinikum Weiden; Brustzentrum Weiden
Germany Gemeinschaftspraxis Hämatologie / Onkologie Wiesbaden
Hungary Municipal Hospital of Uzsoki Utca; Centre of Oncoradiology Budapest
Hungary Semmelweis Egyetem Onkologiai Központ Budapest
Hungary Josa Andras Korhaz; Dept of Oncoradiology Nyíregyháza
Hungary Vas Megyei Markusovszky Korhaz ; Pulmonology Szombathely
Italy USL 8 Ospedale San Donato; Oncology Endocrinology Arezzo Toscana
Italy Azienda Ospedaliera S.G. Moscati; Division of Medical Oncology Avellino Campania
Italy Irccs Centro Di Riferimento Oncologico (CRO); Dipartimento Di Oncologia Medica Aviano Friuli-Venezia Giulia
Italy Ospedale Santa Maria Annunziata; Oncologia Bagno a Ripoli Toscana
Italy Asst Papa Giovanni XXIII; Oncologia Medica Bergamo Lombardia
Italy Az. Osp. S. Orsola Malpighi; Istituto Di Oncologia Seragnoli Bologna Emilia-Romagna
Italy Az. Osp. Spedali Civili; Divisione Di Oncologia - Iii Medicina Brescia Lombardia
Italy A.O.U. Cagliari-P.O. Monserrato;U.O. Oncologia Cagliari Sardegna
Italy Fondazione Del Piemonte Per L'oncologia Ircc Di Candiolo; Dipartimento Oncologico Candiolo Piemonte
Italy Ospedale Di Casalpusterlengo; Day Hospital Oncologico Casalpusterlengo Lombardia
Italy Centro Catanese Di Oncologia; Oncologia Medica Catania Sicilia
Italy Az. Osp. Pugliese; Dh Oncologico Catanzaro Calabria
Italy Policlinico Ospedaliero Ss Annunziata; U.O. Di Clinica Oncologica Chieti Abruzzo
Italy Ospedale Valduce; Dept. Di Oncologia Medica Como Lombardia
Italy Arcispedale S.Anna; Oncologia Medica Cona (Ferrara) Veneto
Italy Az. Osp. Mariano Santo; Centro Oncologico Cosenza Calabria
Italy Ospedale S. Croce Di Fano; Servizio Oncologia Fano Marche
Italy Azienda Ospedaliero-Universitaria Careggi;S.C. Oncologia Medica 1 Firenze Toscana
Italy IRCCS Istituto Nazionale Per La Ricerca Sul Cancro (IST); Oncologia Medica A Genova Liguria
Italy Ospedale S. Andrea Est Felettino; Oncologia Medica La Spezia Liguria
Italy Ospedale S. Maria Goretti; Divisione Di Oncologia Medica Latina Lazio
Italy Ospedale Vito Fazzi; Div. Oncoematologia Lecce Puglia
Italy ASST DI LECCO; Oncologia Medica Lecco Lombardia
Italy ASST OVEST MILANESE; Oncologia Medica Legnano Lombardia
Italy Ospedale Campo Di Marte; Dipartimento Oncologico Lucca Toscana
Italy Az. Osp. Carlo Poma; Divisione Di Oncologia Medica Mantova Lombardia
Italy Opspedale Morgagni - Pierantoni; Dept. Di Oncologia Medica Meldola Emilia-Romagna
Italy Asst Santi Paolo E Carlo; Unita Operativa Di Oncologia Medica Milano Lombardia
Italy Istituto Europeo Di Oncologia Milano Lombardia
Italy Az. Osp. Cardarelli; Divisione Di Oncologia Napoli Campania
Italy Ist. Uni Federico Ii; Divisione Di Oncologia Medica - Dpt. Di Medicina Interna Napoli Campania
Italy Istituto Tumori Fondazione Pascale; Endocrinologia Oncologica Napoli Campania
Italy Ospedale S. Gennaro; Oncologia Medica Napoli Campania
Italy Az. Osp. M. Ascoli G. Di Cristina; Oncologia Medica Palermo Sicilia
Italy La Maddalena Casa Di Cura Di Alta Specialita; Oncologia Chirurgica Palermo Sicilia
Italy Fondazione Salvatore Maugeri; Divisione Di Oncologia Medica Pavia Lombardia
Italy Fondazione Salvatore Maugeri; Servizio Di Prevenzione Oncologica Pavia Lombardia
Italy Irccs Policlinico S. Matteo - Uni Pavia; Clinica Medica I Div. Med. Int. Onc. Medica E Gastroent. Pavia Lombardia
Italy Azienda Usl 7; Dept. Oncologico Poggibonsi Toscana
Italy Ospedale Degli Infermi Di Biella; Reparto Oncologia Medica Ponderano (BI) Piemonte
Italy Ospedale San Carlo; Day Hospital Oncologia Medica Potenza Basilicata
Italy Az. Osp. ; Divisione Di Oncologia Ragusa Sicilia
Italy Ospedale Provinciale Santa Maria delle Croci Ravenna Emilia-Romagna
Italy Ospedale Oncologico Regionale; U.O. Oncologia Medica Ed Ematologia Rionero in Vulture Basilicata
Italy Azienda Complesso Ospedaliero S. Filippo Neri; Divisione Di Oncologia Medica Roma Lazio
Italy Istituto Regina Elena; Oncologia Medica A Roma Lazio
Italy Ospedale San Giacomo in Augusta; Reparto Oncologia Roma Lazio
Italy Policlinico Militare Di Roma; Reparto Di Oncologia Roma Lazio
Italy Policlinico Universitario Campus Biomedico; Uoc Oncologia Medica Roma Lazio
Italy IRCCS Ospedale Casa Sollievo Della Sofferenza; Oncologia San Giovanni Rotondo Puglia
Italy Polo Ospedaliero Santorso Santorso Veneto
Italy Azienda Ospedaliero Universitaria Di Sassari;Oncologia Sassari Sardegna
Italy A.O. Città della Salute e della Scienza - Presidio Molinette; divisione oncologia medica Torino Piemonte
Italy Ospedale Sant'Anna - Uni Di Torino; Unita Di Oncologia Ginecologica Torino Piemonte
Italy Ospedale Santa Chiara; Oncologia Medica Trento Trentino-Alto Adige
Italy Centro Soc. Oncologico, Azienda Sanitaria Universitaria Integrata Trieste; CENTRO ONCOLOGICO Trieste Friuli-Venezia Giulia
Italy Ospedale Di Circolo; Centro Di Senologia Varese Lombardia
Italy Ospedale Civile S. Bortolo; Divisione Di Oncologia Vicenza Veneto
Poland Regionalne Centrum Onkologi; Oddzial Chorob Wewnetrznych I Onkologii Bydgoszcz
Poland Oddzial Chemioterapii Szpitala Klinicznego Nr 1 w Poznaniu Poznan
Spain Complejo Hospitalario de Jaen-Hospital Universitario Medico Quirurgico; Servicio de Oncologia Jaen
Spain Hospital Universitario de Canarias;servicio de Oncologia La Laguna Tenerife
Spain Hospital Regional Universitario Carlos Haya Malaga
Spain Hospital General de Mataro; Servicio de Oncologia Mataro Barcelona
Spain Hospital de Navarra; Servicio de Oncologia Navarra
Spain Corporacio Sanitaria Parc Tauli; Servicio de Oncologia Sabadell Barcelona
Spain Hospital Universitario Virgen del Rocio; Servicio de Oncologia Sevilla
Spain Complejo Hospitalario de Toledo- H. Virgen de la Salud; Servicio de Oncologia Toledo
Spain Hospital Universitario Miguel Servet; Servicio Oncologia Zaragoza
Sweden Gävle sjukhus onkologkliniken Gaevle
Sweden Lanssjukhuset Ryhov; Onkologkliniken Jonkoping
Sweden Länssjukhuset Kalmar; Oncology Kalmar
Sweden Centralsjukhuset Karlstad, Onkologkliniken Karlstad
Sweden Uni Hospital Linkoeping; Dept. of Oncology Linköping
Sweden Skånes University Hospital, Skånes Department of Onclology Lund
Sweden Karolinska Hospital; Oncology - Radiumhemmet Stockholm
Sweden Länssjukhuset Sundsvall, Onkologkliniken Sundsvall
Sweden Norrlands Universitetssjukhus, Umeå, Cancercentrum; Dept of Oncology Umea
United Kingdom Aberdeen Royal Infirmary; Medical Oncology Dept Aberdeen
United Kingdom Belfast City Hospital; Dept of Oncology Belfast
United Kingdom Velindre Cancer Centre; Oncology Dept Cardiff
United Kingdom Broomfield Hospital; Oncology Chelmsford
United Kingdom Ninewells Hospital; Dept of Radiotherapy & Oncology Dundee
United Kingdom Royal Devon & Exeter Hospital; Oncology Centre Exeter
United Kingdom Glasgow Western Infirmary; Dept of Radiotherapy Glasgow
United Kingdom Huddersfield Royal Infirmary Huddersfield
United Kingdom Queen Elizabeth Hospital Kings Lynn
United Kingdom Charing Cross Hospital; Medical Oncology. London
United Kingdom St George'S Hospital; Oncology Research Office /Oncology Opd London
United Kingdom St Thomas Hospital; Medicine Div. London
United Kingdom Christie Hospital; Breast Cancer Research Office Manchester
United Kingdom James Cook Uni Hospital Middlesborough
United Kingdom Newcastle General Hospital Newcastle Upon Tyne
United Kingdom Royal Preston Hosptial Preston
United Kingdom Oldchurch Hospital Romford
United Kingdom Salisbury District General Hospital; Medical Oncology Dept Salisbury
United Kingdom Royal Shrewsbury Hospitals Nhs Trust; Oncology Shrewsbury
United Kingdom Southampton General Hospital; Medical Oncology Southampton
United Kingdom Worthing Hospital; Sussex Oncology Centre, Worthing Breast Unit Worthing
United Kingdom Yeovil District Hospital; Macmillan Cancer Unit Yeovil
United Kingdom Airedale General Hospital; Oncology York

Sponsors (1)

Lead Sponsor Collaborator
Hoffmann-La Roche

Countries where clinical trial is conducted

Austria,  Belgium,  Germany,  Hungary,  Italy,  Poland,  Spain,  Sweden,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of symptomatic congestive heart failure\n(CHF) using New York Heart Association class II, III and IV, and cardiac death On treatment and up to 5 years follow-up
Secondary Time to onset and the time to recovery of symptomatic congestive heart failure On treatment and up to 5 years follow-up
Secondary Incidence of asymptomatic cardiac failure and other significant cardiac conditions On treatment and up to 5 years follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT04681911 - Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer Phase 2
Completed NCT04890327 - Web-based Family History Tool N/A
Terminated NCT04066790 - Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer Phase 2
Completed NCT03591848 - Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility N/A
Recruiting NCT03954197 - Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients N/A
Terminated NCT02202746 - A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer Phase 2
Active, not recruiting NCT01472094 - The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
Withdrawn NCT06057636 - Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study N/A
Completed NCT06049446 - Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
Recruiting NCT05560334 - A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations Phase 2
Active, not recruiting NCT05501769 - ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer Phase 1
Recruiting NCT04631835 - Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer Phase 1
Completed NCT04307407 - Exercise in Breast Cancer Survivors N/A
Recruiting NCT03544762 - Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation Phase 3
Terminated NCT02482389 - Study of Preoperative Boost Radiotherapy N/A
Enrolling by invitation NCT00068003 - Harvesting Cells for Experimental Cancer Treatments
Completed NCT00226967 - Stress, Diurnal Cortisol, and Breast Cancer Survival
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06019325 - Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy N/A
Recruiting NCT06006390 - CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors Phase 1/Phase 2